Normative amygdala fMRI response during emotional processing as a trait of depressive symptoms in the UK Biobank
Psychological Medicine · 2025
DOI: 10.1017/s0033291725101797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychological Medicine, 2025. Verfasst von Jerke J van den Berg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering and Physics, https://ror.org/03t4gr691Amsterdam UMC Location AMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Amygdala, Emotions, Depression. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ITEA3.
Themen: Depression
Abstract (Originalsprache)
Background
Heightened reactivity in the amygdala measured by functional magnetic resonance imaging during emotional processing is considered a potential biomarker for clinical depression. Still, it is unknown whether this is also true for depressive symptoms in the general population, and – when in remission after recurrent depressive episodes – it is associated with future episodes.
Methods
Using the UK Biobank population study ( n = 11,334), we investigated the association of amygdala reactivity during negative facial stimuli, focusing on lifetime depression (trait), depressive symptoms (state), and the modulating effect of antidepressant (AD) treatment thereof. We employed normative modeling (NM) to better incorporate population heterogeneity of the amygdala activity.
Results
In line with a previous study, depressive symptoms (state) over the last 2 weeks were not associated with the amygdala reactivity signal. Rather, our results indicate a significant positive association ( p = 0.03, ω 2 = 0.001) between amygdala response and the recurrence of depressive episodes (trait). Longitudinal analysis revealed that the group that had experienced a single depressive episode before showed a significantly increased amygdala response after additional episodes ( p = 0.03, ω 2 = 0.017). ADs were not associated with amygdala response directly, but decreased associations within episode recurrence severity.
Conclusions
The amygdala response to negative stimuli was associated with an individual’s risk of recurrence of depressive episodes, and AD treatment reduced these associations. This study highlights the relevance of amygdala reactivity as a trait, but not a state biomarker for (recurrent) depression. Moreover, it demonstrates the benefit of applying NM in the context of population data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Engineering and Physics, https://ror.org/03t4gr691Amsterdam UMC Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
- Radiology and Nuclear Medicine, https://ror.org/03t4gr691Amsterdam UMC Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Psychiatry, https://ror.org/01yb10j39Radboud UMC, Nijmegen, The Netherlands.
- Donders Institute for Brain, Cognition and Behavior, Radboud University, The Netherlands.
ORCID-Profile: Jerke J van den Berg, Henricus G Ruhé, Henk A Marquering, Liesbeth Reneman, Matthan W A Caan
Förderung
- ITEA3
Zitieren
APA
van den Berg, J. J., Ruhé, H. G., Marquering, H. A., Reneman, L., & Caan, M. W. A. (2025). Normative amygdala fMRI response during emotional processing as a trait of depressive symptoms in the UK Biobank. Psychological Medicine. https://doi.org/10.1017/s0033291725101797
Vancouver
van den Berg JJ, Ruhé HG, Marquering HA, Reneman L, Caan MWA. Normative amygdala fMRI response during emotional processing as a trait of depressive symptoms in the UK Biobank. Psychological Medicine. 2025. doi:10.1017/s0033291725101797
BibTeX
@article{vandenBerg2025,
author = {van den Berg, Jerke J and Ruhé, Henricus G and Marquering, Henk A and Reneman, Liesbeth and Caan, Matthan W A},
title = {Normative amygdala fMRI response during emotional processing as a trait of depressive symptoms in the UK Biobank},
journal = {Psychological Medicine},
year = {2025},
doi = {10.1017/s0033291725101797}
}
EUVIMED